Organogenesis
Price & Volume
Stats
See moreOpen | $4.78 |
Previous Close | $4.91 |
Day Range | $4.76-$4.92 |
52W Range | $2.21-$6.71 |
Market Cap | $592.2M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $482M |
Revenue Growth (YoY) | 27.1% |
Gross Profit (12 Mos) | $366.3M |
Diluted EPS | -$0.01 |
News
See moreYahoo Finance • 20 days ago
Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
Yahoo Finance • 24 days ago
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
Yahoo Finance • 3 months ago
Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025
Yahoo Finance • last year
Organogenesis (ORGO) Q3 2023 Earnings Call Transcript
About
CEO | Mr. Gary S. Gillheeney Sr. |
Address | 85 Dan Road, Canton, MA, United States, 02021 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 869 |
